Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human
hemokinin
-1 (h
HK-1
) and its truncated form h
HK-1
(4-11) are mammalian
tachykinin
peptides encoded by the
TAC4
gene identified in human, and the biological functions of these peptides have not been well investigated. The tachykinins have shown immuno-regulatory activities in humans. In the present study, we investigated the effects of h
HK-1
and h
HK-1
(4-11) on the proliferation and differentiation of a human promyelocyte leukemia cell line, HL-60. It is noteworthy that h
HK-1
(1-300muM) displayed inhibitory effects on the proliferation of HL-60 cells in a dose- and time-dependent manner. The effect of suppressing proliferation induced by these peptides was accompanied by an accumulation of cell cycle in the S phase. Moreover, this peptide induced differentiation of HL-60 cells by significantly increasing the NBT-reduction activity. The effects induced by h
HK-1
(4-11) on HL-60 cells were similar to that of h
HK-1
, indicating that it is the active fragment of h
HK-1
. However these effects induced by h
HK-1
or h
HK-1
(4-11) were not antagonized by the NK(1) receptor antagonist SR140333 or the NK(2) receptor antagonist SR48968. All the results indicated that h
HK-1
and h
HK-1
(4-11) were able to significantly inhibit proliferation and induce differentiation and S phase arrest of a human promyelocyte leukemia cell line HL-60, which may not be mediated through the activation of classical
tachykinin
NK(1) receptors and
tachykinin
NK(2) receptors. Our observations also implied that h
HK-1
and h
HK-1
(4-11) could act as immunomodulatory factors in cancer chemotherapy.
...
PMID:Human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, suppress proliferation and induce differentiation in HL-60 cells. 1943 25
Hemokinin-1 (HK-1) is a novel peptide described as a member of the
tachykinin
family.
Substance P
(SP), a representative member of the
tachykinin
family, has been well characterized and is thought to play a part in inflammation and pain. While several studies indicate that HK-1 is involved in inflammation and pain, the biological functions of HK-1 are not fully understood. In the present study we investigated the expression of HK-1 mRNA (
TAC4
) and SP mRNA (TAC1) in the dorsal spinal cord of rat after inducing peripheral inflammation by administering complete Freund's adjuvant (CFA) into the hind paw, using real-time RT-PCR. In the behavioral studies, the thresholds of withdrawal response of the hind paw to thermal stimulation significantly decreased on the ipsilateral side, but not on the contralateral side, 6 hours after CFA injection and thermal hyperalgesia persisted until 4 days after CFA injection. The level of HK-1 mRNA expression significantly increased on the bilateral sides of the dorsal spinal cord 6 hours after CFA injection and returned to the base level 1 day after injection. On the other hand, the level of SP mRNA expression did not change in the spinal cord 6 hours and 1 day after CFA injection. These results indicate that HK-1 may contribute to inflammatory pain, in the early phase, in a different manner from SP.
...
PMID:[Expression of hemokinin-1 in rat spinal cord after peripheral inflammation]. 1961 May 86
Two
tachykinin
peptides,
substance P
(SP) and
hemokinin
-1 (HK-1), and three transient receptor potential (TRP) channels, TRPV1, TRPA1 and TRPM8, are similarly localized in the spinal dorsal horn and dorsal root ganglion, suggesting that TRP channels may be related or modulated by these
tachykinin
peptides. Thus, to clarify whether the responses of TRP channels are modulated by SP or HK-1, the effects of pretreatment with SP or HK-1 on the induction of scratching behavior by TRP channel agonists were examined. Pretreatment with SP or HK-1 enhanced the induction of scratching behavior by resiniferatoxin, a TRPV1 agonist, whereas scratching behavior induced by menthol, a TRPM8 agonist, was suppressed by pretreatment with these peptides. On the other hand, pretreatment with SP, but not HK-1, suppressed the induction of scratching behavior by cinnamaldehyde, a TRPA1 agonist. Taken together, the present results indicate that SP or HK-1 differentially modulated the response of TRPV1, TRPA1 or TRPM8 channel.
...
PMID:Differential effects of substance P or hemokinin-1 on transient receptor potential channels, TRPV1, TRPA1 and TRPM8, in the rat. 1992 30
It is known that intrathecal administration of
substance P
(SP) induces thermal hyperalgesia, whereas
hemokinin
-1 (HK-1), a member of the same
tachykinin
family as SP, hardly induces thermal hyperalgesia; however, the underlying mechanism remains to be elucidated. Therefore, we aimed to clarify which amino acid of these peptides contributes to the induction of thermal hyperalgesia. When two chimera peptides between the N-terminal region of SP and the C-terminal region of HK-1, and vice versa, SP (1-5)/HK-1 and HK-1 (1-5)/SP, were intrathecally administered, SP (1-5)/HK-1 induced thermal hyperalgesia whereas HK-1 (1-5)/SP had hardly any effect; furthermore, thermal hyperalgesia was induced by only C-terminal fragments of HK-1 and SP. These findings indicate that the N-terminal region of HK-1 is involved in the non-induction of thermal hyperalgesia. Next, we synthesized and intrathecally administered these chimera peptides in which part of the N-terminal region of HK-1 was replaced with that of SP, and vice versa, and all synthesized peptides induced thermal hyperalgesia. Both SP (1-2)/HK-1 and HK-1 (1-4)/SP certainly induced thermal hyperalgesia, although HK-1 and HK-1 (1-5)/SP had hardly any effect; therefore, it is probable that Ser at the 2nd position and Arg at the 5th position of HK-1 may be involved in the non-induction of thermal hyperalgesia. Furthermore, peptides in which amino acid at the 3rd and/or 4th positions of HK-1 was replaced with that of SP were synthesized. Intrathecal administration of HK-1 (1-2,4-5)/SP, but not HK-1 (1-2,5)/SP and HK-1 (1-3,5)/SP, hardly induced thermal hyperalgesia. These findings indicate that three amino acids, Ser, Thr and Arg at the 2nd, 4th and 5th positions of HK-1, respectively, regulate the induction of thermal hyperalgesia by HK-1.
...
PMID:The amino-terminal region of hemokinin-1 regulates the induction of thermal hyperalgesia in rats. 2017 98
Hemokinin-1 is a novel mammalian
tachykinin
cloned from mouse bone marrow. At present, pharmacological profile and physiological role of
hemokinin
-1 are still unclear. In the present study, we found that intrathecal (i.t.) administration of
hemokinin
-1 (0.00625-1.6 nmol) induced nociceptive responses consisting of scratching, biting and licking, which resemble
substance P
-induced behavioral responses in mice. The behaviors evoked by low-dose of
hemokinin
-1 (0.0125 nmol) were dose-dependently inhibited by i.t. co-administration of CP-99,994, a non-peptidic
tachykinin
NK(1) receptor antagonist, whereas high-dose of
hemokinin
-1 (0.1 nmol)-induced behaviors were not affected. Moreover, sendide, a peptidic
tachykinin
NK(1) receptor antagonist, failed to reduce the behavioral responses of both low- and high-dose of
hemokinin
-1. In contrast,
substance P
-induced behaviors were completely suppressed by both CP-99,994 and sendide. These results suggest that
hemokinin
-1 plays an important role in pain transmission at spinal cord. Moreover, the mechanism of
hemokinin
-1-induced nociceptive behaviors may be dose-dependent, and distinct from
substance P
-induced nociceptive behaviors.
...
PMID:Characterization of intrathecally administered hemokinin-1-induced nociceptive behaviors in mice. 2045 71
Rat/mouse
hemokinin
-1 (r/m
HK-1
), human
hemokinin
-1 (h
HK-1
) and human
hemokinin
-1(4-11) (h
HK-1
(4-11)) are members of the
tachykinin
family. In the present study, the coronary vascular activities and cardiac functions of r/m
HK-1
, h
HK-1
and h
HK-1
(4-11) were investigated in isolated, spontaneously beating guinea pig hearts. Bolus injections of r/m
HK-1
caused decrease in perfusion pressure indicative of coronary vasodilation, which was primarily due to the action on
tachykinin
NK1 receptors on vascular endothelial cells, causing the release of nitric oxide that relaxed the coronary vessels. H
HK-1
caused biphasic perfusion pressure changes that were coronary vasodilation followed by coronary vasoconstriction. The mechanisms involved in the vasodilation induced by h
HK-1
were similar to that of r/m
HK-1
while the mechanisms for coronary vasoconstriction were mediated through the activation of
tachykinin
NK2 receptors on coronary sympathetic neurons to release catecholamines. H
HK-1
(4-11) only produced coronary vasoconstriction and the mechanisms involved in this effect were similar to that of h
HK-1
in vasoconstriction. Moreover, r/m
HK-1
and h
HK-1
produced similar decreases in heart rate indicative of negative chronotropic responses and the decreases were mainly mediated through the activation of
tachykinin
NK1 receptors to release ACh acting on muscarinic receptors. H
HK-1
(4-11) also produced negative chronotropic response, which was mainly mediated through
tachykinin
NK2 receptors and muscarinic receptors. Our present results provide evidence that all of the three tachykinins could influence cardiac function and coronary vascular activity in the isolated guinea pig heart.
...
PMID:Effects of rat/mouse hemokinin-1, human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on rate and perfusion pressure in the isolated guinea pig heart. 2047 76
Tachykinins encoded by the
preprotachykinin
A (TAC1) gene such as
substance P
(SP) and
neurokinin A
(
NKA
) are involved in neurogenic inflammatory processes via predominantly neurokinins 1 and 2 (NK1 and NK2) receptor activation, respectively. Endokinins and hemokinins encoded by the
TAC4
gene also have remarkable selectivity and potency for the NK1 receptors and might participate in inflammatory cell functions. The aim of the present study was to investigate endotoxin-induced airway inflammation and consequent bronchial hyper-reactivity in TAC1(-/-), NK1(-/-) and also in double knockout (TAC1(-/-)/NK1(-/-)) mice. Sub-acute interstitial lung inflammation was evoked by intranasal Escherichia coli lipopolysaccharide (LPS) in the knockout mice and their wildtype C57BL/6 counterparts 24 h before measurement. Respiratory parameters were measured with unrestrained whole body plethysmography. Bronchoconstriction was induced by inhalation of the muscarinic receptor agonist carbachol and Penh (enhanced pause) correlating with airway resistance was calculated. Lung interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) concentrations were measured with ELISA. Histological evaluation was performed and a composite morphological score was determined. Myeloperoxidase (MPO) activity in the lung was measured with spectrophotometry to quantify the number of infiltrating neutrophils/macrophages. Airway hyper-reactivity was significantly reduced in the TAC1(-/-) as well as the TAC1(-/-)/NK1(-/-) groups. However, LPS-induced histological inflammatory changes (perivascular/peribronchial oedema, neutrophil infiltration and goblet cell hyperplasia), MPO activity and TNF-alpha concentration were markedly diminished only in TAC1(-/-) mice. Interestingly, the concentrations of both cytokines, IL-1beta and TNF-alpha, were significantly greater in the NK1(-/-) group. These data clearly demonstrated on the basis of histology, MPO and cytokine measurements that TAC1 gene-derived tachykinins, SP and
NKA
, play a significant role in the development of endotoxin-induced murine airway inflammation, but not solely via NK1 receptor activation. However, in inflammatory bronchial hyper-responsiveness other tachykinins, such as
hemokinin
-1 acting through NK1 receptors also might be involved.
...
PMID:Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation. 2057 32
Since tachykinins appear to be involved in the pathogenesis of allergic asthma, we investigated a possible association between 28 single nucleotide polymorphisms of the
tachykinin
genes TAC1, TAC3 and
TAC4
, and asthma susceptibility. A case-control study was conducted on 102 patients and 100 healthy subjects from the Canary Islands (Spain). A significant association with asthma was observed for two SNPs: rs2291855 in the TAC3 gene conferring asthma protection (Odds ratio [OR]: 0.46; 95% Confidence Interval [CI]: 0.22-0.97; P=0.038), and rs4794068 in the
TAC4
gene associated with an increased risk for asthma (OR: 1.94; 95% CI: 1.06-3.54; P=0.03). The present study represents a preliminary step in elucidating the association between
tachykinin
gene polymorphisms and asthma susceptibility.
...
PMID:Common variants of the neuropeptide expressing tachykinin genes and susceptibility to asthma: a case-control study. 2058 Apr 42
Endokinins, encoded by the human
preprotachykinin C
(
PPT-C
)/
TAC4
gene, are peptides that consist of
endokinin
A (EKA), B (EKB), C (
EKC
) and D (EKD) and belong to the
tachykinin
family. Intrathecal injection of
EKC
/D (using the common carboxyl-terminal duodecapeptide in
EKC
and EKD) markedly attenuated the induction of thermal hyperalgesia and scratching behavior by intrathecal administration of
substance P
(SP), indicating that
EKC
/D has an antagonistic effect on the neurokinin 1 receptor (NK1R), SP-preferring receptor, at the spinal level; however, the pharmacological function of
EKC
/D at the periphery is not yet understood. Therefore, to clarify the effect of
EKC
/D on the peripheral tissue, the effect of subcutaneous injection of
EKC
/D on carrageenan-induced inflammation was examined. Subcutaneous injection of
EKC
/D attenuated an increase in paw volume following carrageenan-induced inflammation in a dose-dependent manner. Indeed, the increased paw volume was significantly decreased 40 min after treatment with 10(-4) M (10 nmol) and 10(-3) M (100 nmol)
EKC
/D (100 microl/rat). Similarly, injection of NK1R antagonists such as L-703,606 and Spantide I (10(-3) M) attenuated the increased paw volume following inflammation. Furthermore, the reduced withdrawal latency evoked by inflammation following subcutaneous injection of carrageenan was also dose-dependently attenuated by
EKC
/D administration. These results indicate that subcutaneous injection of
EKC
/D elicits an anti-inflammatory effect on carrageenan-induced inflammation.
...
PMID:Subcutaneous injection of endokinin C/D attenuates carrageenan-induced inflammation. 2063 46
Hemokinin-1 (HK-1), encoded by the
TAC4
gene, is a
tachykinin
peptide that is predominantly expressed in non-neuronal cells, such as immune cells. We have disrupted the mouse
TAC4
gene to obtain a better understanding of the actions of HK-1 during hematopoiesis. We demonstrate here that
TAC4
(-/-) mice exhibit an increase of CD19(+)CD117(+)HSA(+)BP.1(-) "fraction B" pro-B cells in the bone marrow, whereas pre-B, immature, and mature B cells are within the normal range. We show that in vitro cultures derived from
TAC4
(-/-) bone marrow, sorted "fraction B" pro-B cells or purified long-term reconstituting stem cells, contain significantly higher numbers of pro-B cells compared with controls, suggesting an inhibitory role for HK-1 on developing B cells. Supporting this idea, we show that addition of HK-1 to cultures established from long-term reconstituting stem cells and the newly described intermediate-term reconstituting stem cells leads to a significant decrease of de novo generated pro-B cells. Based on our studies, we postulate that HK-1 plays an inhibitory role in hematopoiesis, and we hypothesize that it may be part of the bone marrow microenvironment that supports and regulates the proliferation and differentiation of hematopoietic cells.
...
PMID:Targeted deletion of the tachykinin 4 gene (TAC4-/-) influences the early stages of B lymphocyte development. 2066 Jul 92
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>